0001213900-21-046687.txt : 20210903 0001213900-21-046687.hdr.sgml : 20210903 20210903170411 ACCESSION NUMBER: 0001213900-21-046687 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210901 FILED AS OF DATE: 20210903 DATE AS OF CHANGE: 20210903 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Berger Mark Stanley CENTRAL INDEX KEY: 0001700283 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36374 FILM NUMBER: 211237297 MAIL ADDRESS: STREET 1: 140 RIVERSIDE DRIVE STREET 2: APT. 9K CITY: NEW YORK STATE: NY ZIP: 10024 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Actinium Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001388320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 880378336 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 275 MADISON AVENUE, 7TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10016 BUSINESS PHONE: 646-677-3875 MAIL ADDRESS: STREET 1: 275 MADISON AVENUE, 7TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10016 FORMER COMPANY: FORMER CONFORMED NAME: Cactus Ventures, Inc. DATE OF NAME CHANGE: 20070130 4 1 ownership.xml OWNERSHIP DOCUMENT X0306 4 2021-09-01 0 0001388320 Actinium Pharmaceuticals, Inc. ATNM 0001700283 Berger Mark Stanley C/O ACTINIUM PHARMACEUTICALS, INC., 275 MADISON AVENUE, 7TH FLOOR NEW YORK, NY 10016 0 1 0 0 Chief Medical Officer Stock Option (Right to Buy) 6.07 2021-09-01 4 A 0 67164 0 A 2031-09-01 Common Stock 67164 67164 D This price represents the closing price of the Company's common stock on the date of the board of directors approval of the grant. Pursuant to the terms of the Company's Amended and Restated 2013 Stock Plan and 2019 Stock Plan, 2% of the options will vest each month from September 1, 2021 until fully vested. /s/ Mark Berger 2021-09-03